Please login to the form below

Not currently logged in
Email:
Password:

Cardiome

This page shows the latest Cardiome news and features for those working in and with pharma, biotech and healthcare.

Correvio crumbles as FDA panel rejects AFib drug

Correvio crumbles as FDA panel rejects AFib drug

Brinavess is an anti-arrhythmic drug that blocks potassium and sodium channels in the upper heart chambers, and has been in development by Correvio (formerly Cardiome) for many years. ... Cardiome’s latest application is based on a post-marketing

Latest news

  • MSD strikes vernakalant deal with Astellas

    In October 2003, Astellas US was granted an exclusive licence to develop and commercialise vernakalant iv in Canada, Mexico and the US by Cardiome Pharma Corp.

  • The power of small

    Rhythm Search Developments (RSD), which evolved into Nortran Pharmaceuticals and subsequently Cardiome Pharma.

  • New drug approvals point to possible blockbusters

    The list includes the cholesterol drug Cordaptive from Merck &Co, the heart medication Kynapid (vernakalant) from Cardiome Pharma and the anaesthesia-complication drug Sugammadex from Schering-Plough. ... Kynapid from Cardiome Pharma would be the first

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Pharma deals during November 2013 Pharma deals during November 2013

    In a similar vein, Cardiome completed its acquisition of Correvio, a privately owned Swiss company (previously known as Iroko Cardio), achieving a European infrastructure for marketing its products. ... Cardiome has acquired Correvio through the purchase

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Merck & Co’s Jürgen Polifka joins Cardiome Merck & Co’s Jürgen Polifka joins Cardiome

    We are extremely pleased to have Dr Polifka join Cardiome at such a critical time in its history," said Karim Lalji, Cardiome's chief commercial officer. ... His personal experience with Brinavess at MSD and deep understanding of the European hospital

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics